1

Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrrelation of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987;316:780-9.

2

Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H et al. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy-a review. Prog Cardiovasc Dis 1985;28:1-83.

3

Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92:1680-92.

4

Watkins H, Rosenzweig A, Hwang DS, Levi T, McKEnna W, Slidman CH et al. Characteristics and prognostic implications of myosin missens mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.

5

Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997;350:127-33.

6

Maron BJ, Moller JH, Seidman CE, Vincent GM, Dietz HC, Moss AJ et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan Syndrome. Circulation 1998;98:1460-71.

7

Liouville H. Retrecissement cardiaque sous aortique. Gaz Med Paris 1869;24:161.

8

Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discusion of nomenclature. Am J Cardiol 1979;43:1242-4

9

Maron BJ, Gaffney FA, Jeresaty RM. Task force III: hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol 1985;6:1215-7.

10

Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol 1981;48:418-28.

11

Yamaguchi H, Ishimura T, Nishiyama SH, Nagasaki F, Nakanishi Sh, Takatsu FA et al. Hypertrophic cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979;44:401-12.

12

Candell-Riera J, Alvarez-Auñón A, Balda-Caravedo, García del Castillo H, Soler Soler J. Clasificación de la miocardiopatía hipertrófica mediante ecocardigrafía bidimensional. Rev Esp Cardiol 1986;39:358-63.

13

Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983;2:437-44.

14

Yuste P, García-Fernandez MA. Ecocardiografía, técnica-M y bidimensional en el análisis de las miocardiopatías. Rev Lat Cardiol 1981;2:443-55.

15

Romero-Farina G, Candell-Riera J, Pereztol-Valdés O, Galve-Basilio E, Palet-Balart J, García del Castillo H et al. Clasificación morfológica de la miocardiopatía hipertrófica mediante tomogammagrafia miocárdica. Comparación con la clasificación ecocardiográfica. Rev Esp Cardiol 2000 (en prensa).

16

Pons-Lladó G, Carreras F, Borrás X, Palmer J, Llauger J, Bayés de Luna A. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 1997; 79: 1651-6.

17

Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopahty: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708.

18

Comittee on Advanced Cardiac Imaging and Technology, Council on Clinical Cardiology; and Board of Directors, Cardiovascular Council, Society of Nuclear Medicine. Standarization of Cardiac Tomographic imaging. Circulation 1992;86:338-99.

19

Östman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 34: 1813-22

20

Alvarez-Auñón A, Candell-Riera J, Balda-Caravedo F, García del Castillo H, Soler-Soler J. ¿Existen diferencias ecocardiográficas entre los pacientes sintomáticos afectos de miocardiopatía hipertrófica?. Rev Esp Cardiol 1988; 41: 143-7.

21

Smith WH, Kastner RJ, Calnon DA, Segalla D, Beller GA, Watson DD. Quantitative gated single photon emission computed tomography imaging: A counts-based method for display and measurement of regional and global ventricular systolic function. J Nucl Cardiol 1997;4:451-63.

22

Suzuki Y, Kadota K, Nohara R, Tamaki S, Kambara H, Yoshida A et al. Recognition of regional hypertrophy in hypertrophic cardiomyopathy using thallium-201 emission computed tomography: comparison with two-dimensional echocardiography. Am J Cardiol 1984:53:1095-102.

23

Bulkley BH, Rouleau J, Strauss HW, Pitt B. Idiopathic hypertrophic subaortic stenosis: Detection by thallium 201 myocardial perfusion imaging. N Engl J Med 1975;293:1113-6.

24

Maron BJ, Spirito P, Chiarella F, Vecchio C. Unusual distribution of left ventricular hypertrophy in obstructive hypertrophic cardiomyopathy: localized posterobasal free wall thickening in two patients. J Am Coll Cardiol 1985;5:1474-7.

25

Lewis JF, Maron BJ. Hypertrophic cardiomyopahty characterized by marked hypertrophy of the posterior left ventricular free wall: significance and clinical implications. J Am Coll Cardiol 1991;18:421-8.

Resumen/Abstract | Introducción | Material y Métodos | Resultados | Discusión | Bibliografía | Versión Completa | Portada Artículo